Glympse Bio

Cambridge, United States

Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response.

$18.0M raised

Dec 2021

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Glympse Bio raised?

Glympse Bio has raised $18.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2021.

Who are Glympse Bio's investors?

Glympse Bio's investors include Temasek, Alumni Ventures, ARCH Venture Partners, Catalio Capital Management, Gilead Sciences.

Where is Glympse Bio headquartered?

Glympse Bio is headquartered in Cambridge, United States.

What does Glympse Bio do?

Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response.

What stage is Glympse Bio at?

Glympse Bio is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 17, 2021.

MLA

"Glympse Bio — Funding & Investors." VCBacked, December 17, 2021, https://www.vcbacked.co/company/glympse-bio. Accessed July 2, 2026.

APA

VCBacked. (2021). Glympse Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/glympse-bio

Wikipedia (cite web)

{{cite web |title=Glympse Bio — Funding & Investors |url=https://www.vcbacked.co/company/glympse-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 17, 2021.